BioCentury
ARTICLE | Clinical News

VA111913: Phase I data

October 12, 2009 7:00 AM UTC

A double-blind, placebo-controlled, U.K. Phase I trial in 98 healthy volunteers showed that single and multiple ascending doses of oral VA111913 were well tolerated. ...